← Back to Clinical Trials
Recruiting NCT06373588

NCT06373588 Empowering Families of Migrant Children and Youth with Special Healthcare Needs

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06373588
Status Recruiting
Phase —
Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Condition Patient Navigation
Study Type INTERVENTIONAL
Enrollment 324 participants
Start Date 2024-08-13
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Patient Navigator

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 324 participants in total. It began in 2024-08-13 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized controlled trial is to test if a patient navigator program improves healthcare experiences and outcomes for migrant families caring for a child or youth with special healthcare needs (i.e. chronic health condition). The main questions are, for migrant families with a child or youth with special healthcare needs: Does a patient navigator reduces barriers to care? Does a patient navigator improve care coordination, caregiver empowerment, caregiver stress and quality of life? What are the healthcare experiences for families with and without the patient navigator intervention? Participants will: * Receive the intervention, i.e., the patient navigator program, or continue with standard of care for 12 months * Fill out questionnaires at 3 time points on barriers to care, caregiver stress, care coordination, and their child's health

Eligibility Criteria

Inclusion Criteria: * Primary caregiver of child/youth ≤18 years who is first- or second-generation migrant, defined as born outside of Canada or having parents born elsewhere, respectively (migrants include immigrants, resettled refugees, refugee claimants (asylum seekers), temporary workers or international students, and other individuals without formal immigration status (undocumented)). * Children or youth with special health care needs, as defined by the CYSHCN Screener, which identifies children who are experiencing one or more functional limitation or service use due to a physical, emotional, behavioural, developmental, or other health condition that has lasted or is expected to last at least 12 months. * Experiencing care transitions between at least 2 of the following: primary care, community-based care, secondary specialist care, and/or hospital-based (acute) care. Exclusion Criteria: * Caregiver living in Canada ≥10 years * Families who are receiving available peer navigation support at sites will be excluded to limit cross-over of interventions.

Contact & Investigator

Central Contact

Melissa Tachdjian

✉ melissa.tachdjian@rimuhc.ca

📞 438-543-2662

Principal Investigator

Patricia Li

PRINCIPAL INVESTIGATOR

Research Institute of the McGill University Health Centre

Frequently Asked Questions

Who can join the NCT06373588 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Patient Navigation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06373588 currently recruiting?

Yes, NCT06373588 is actively recruiting participants. Contact the research team at melissa.tachdjian@rimuhc.ca for enrollment information.

Where is the NCT06373588 trial being conducted?

This trial is being conducted at Toronto, Canada, Montreal, Canada, Montreal, Canada.

Who is sponsoring the NCT06373588 clinical trial?

NCT06373588 is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. The principal investigator is Patricia Li at Research Institute of the McGill University Health Centre. The trial plans to enroll 324 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology